These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipoprotein(a) and atherosclerosis. Scanu AM; Lawn RM; Berg K Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339 [TBL] [Abstract][Full Text] [Related]
3. Genetic basis and pathophysiological implications of high plasma Lp(a) levels. Scanu AM J Intern Med; 1992 Jun; 231(6):679-83. PubMed ID: 1535652 [TBL] [Abstract][Full Text] [Related]
4. [Lipoprotein(a): a link between thrombosis and atherosclerosis?]. Hansen PR Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. Scanu AM Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266 [TBL] [Abstract][Full Text] [Related]
6. Lp(a) as a marker for coronary heart disease risk. Scanu AM Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I35-9. PubMed ID: 1828399 [TBL] [Abstract][Full Text] [Related]
7. Lp(a): a link between thrombosis and atherosclerosis. Scanu AM Eur J Epidemiol; 1992 May; 8 Suppl 1():76-8. PubMed ID: 1387094 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Anglés-Cano E Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a). Link between structure and pathology. Scanu AM Ann Epidemiol; 1992 Jul; 2(4):407-12. PubMed ID: 1342291 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role. Scanu AM Mol Cell Biochem; 1992 Aug; 113(2):127-31. PubMed ID: 1387699 [TBL] [Abstract][Full Text] [Related]
11. Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene. Drayna DT; Hegele RA; Hass PE; Emi M; Wu LL; Eaton DL; Lawn RM; Williams RR; White RL; Lalouel JM Genomics; 1988 Oct; 3(3):230-6. PubMed ID: 2976021 [TBL] [Abstract][Full Text] [Related]
12. The role of lipoprotein(a) in atherogenesis and thrombosis. Hajjar KA; Nachman RL Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793 [TBL] [Abstract][Full Text] [Related]
14. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance]. Armstrong VW Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832 [TBL] [Abstract][Full Text] [Related]
15. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100. Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757 [TBL] [Abstract][Full Text] [Related]
16. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis? Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y Atherosclerosis; 1999 Jun; 144(2):367-74. PubMed ID: 10407497 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform. Guo HC; Michel JB; Blouquit Y; Chapman MJ Arterioscler Thromb; 1991; 11(4):1030-41. PubMed ID: 1829630 [TBL] [Abstract][Full Text] [Related]
18. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis. Forte TM; Nichols AV; Krauss RM; Norum RA J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564 [TBL] [Abstract][Full Text] [Related]
19. [Lipoprotein(a). Its importance as an additional atherosclerosis marker]. Campos E Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184 [TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]